New Delhi: India is likely to allow the export of domestically produced doses of Russia's Sputnik Light COVID-19 vaccine this month, as the shot has yet to be approved in India, two sources with knowledge of the matter told Reuters.
Local media have reported that Indian drugmaker Hetero has already manufactured 2 million doses of the single-shot vaccine, for whose approval the country's drug regulator has sought a separate "immune-bridging clinical trial" in its residents. "Sputnik Light exports are expected to begin from this month," said one of the sources, both of whom declined to be named. "Light is not an approved vaccine in India and stocks are available.